Last10K.com

Glycomimetics Inc (GLYC) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Glycomimetics Inc

HISTORY TOOLS
CIK: 1253689 Ticker: GLYC
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Feb. 28, 2019
Jun. 30, 2018
Document And Entity Information [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Period End DateDec. 31, 2018  
Document Fiscal Year Focus2018  
Document Fiscal Period FocusFY  
Entity Registrant NameGLYCOMIMETICS INC  
Entity Central Index Key0001253689  
Current Fiscal Year End Date--12-31  
Entity Well-known Seasoned IssuerNo  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Filer CategoryAccelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodtrue  
Entity Common Stock, Shares Outstanding 43,168,969 
Entity Public Float  $ 538.3

View differences made from one year to another to evaluate Glycomimetics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Glycomimetics Inc.

Continue

Assess how Glycomimetics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Glycomimetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Expense
Product
Income
Earnings
Geography
Other
Inside Glycomimetics Inc's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statements Of Cash Flows
Statements Of Operations And Comprehensive Loss
Statements Of Stockholders' Equity
Accrued Expenses
Accrued Expenses (Tables)
Accrued Expenses - Summary Of Accrued Expenses (Detail)
Description Of The Business
Description Of The Business (Detail)
Employee Benefit Plan
Employee Benefit Plan (Detail)
Income Taxes
Income Taxes (Tables)
Income Taxes - Nols And Carryforwards (Detail)
Income Taxes - Reconciliation Between Statutory Federal Income Tax Rate And Effective Income Tax Rate (Detail)
Income Taxes - Schedule Of Gross Deferred Tax Asset And Related Valuation Allowance (Detail)
Income Taxes - Tax Cuts And Jobs Act (Details)
Net (Loss) Income Per Share Of Common Stock (Detail)
Net Loss Per Share Of Common Stock
Net Loss Per Share Of Common Stock (Tables)
Operating Leases
Operating Leases (Details)
Operating Leases (Tables)
Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (Tables)
Prepaid Expenses And Other Current Assets - Summary Of Prepaid Expenses And Other Current Assets (Detail)
Property And Equipment
Property And Equipment (Detail)
Property And Equipment (Tables)
Quarterly Financial Information (Unaudited)
Quarterly Financial Information (Unaudited) (Detail)
Quarterly Financial Information (Unaudited) (Tables)
Research And License Agreements
Research And License Agreements - Additional Information (Detail)
Significant Accounting Policies
Significant Accounting Policies (Detail)
Significant Accounting Policies - Recently Issued Accounting Standards (Detail)
Stockholders Equity (Tables)
Stockholders' Equity
Stockholders' Equity - Common Stock Warrants (Detail)
Stockholders' Equity - Company's Stock Option Activity (Detail)
Stockholders' Equity - Equity Offerings (Detail)
Stockholders' Equity - Incentive Plans (Detail)
Stockholders' Equity - Stock-Based Compensation Expense (Detail)
Stockholders' Equity - Summary Of Rsu Activity (Detail)
Stockholders' Equity - Weighted-Average Assumptions (Detail)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Property And Equipment (Detail)

Material Contracts, Statements, Certifications & more

Glycomimetics Inc provided additional information to their SEC Filing as exhibits

Exhibit 23.1: Consents Of Experts And Counsel
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: GLYC
CIK: 1253689
Form Type: 10-K Annual Report
Accession Number: 0001558370-19-001537
Submitted to the SEC: Wed Mar 06 2019 3:30:07 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/glyc/0001558370-19-001537.htm